Literature DB >> 25673507

Advanced glycation end products promote proliferation and suppress autophagy via reduction of Cathepsin D in rat vascular smooth muscle cells.

Mingfeng Ma1, Xiaofan Guo, Ye Chang, Chao Li, Xin Meng, Si Li, Zhen-Xian Du, Hua-Qin Wang, Yingxian Sun.   

Abstract

Autophagy is closely involved in vascular smooth muscle cell (VSMC) function, but little is known about the association between advanced glycation end products (AGEs) and autophagy and its role in AGEs-induced proliferation and migration of VSMCs. The current study investigated the effects of AGEs on the phenotypic modulation and autophagy of VSMCs, as well as the potential underlying mechanisms. Primary rat VSMCs were treated with bovine serum albumin or AGEs. Cell proliferation was detected by MTT assay, real-time cell analyzer and EdU incorporation. Cell cycle was analyzed by Hoechst staining and flow cytometry. The migration of VSMCs was detected by wound-healing assay and transwell migration assay. LC3 transition and p62 accumulation were detected using Western blotting. Acidic vacuoles were measured using AO and MDC staining. Cathepsin D (CatD) was transduced to VSMCs via lentiviral vectors. AGEs enhanced proliferation and migration of primary rat VSMC in a time-dependent manner. AGEs significantly increased LC3-II transition and p62 expression, as well as accumulation of acidic vacuole, which was not further increased by bafilomycin A1. AGEs decreased CatD expression in a time-dependent pattern, and overexpression of CatD prohibited autophagy attenuation mediated by AGEs. CatD overexpression suppressed AGEs-induced proliferation of VSMCs. Nevertheless, CatD exhibited no effects on AGEs-induced migration of VSMCs. AGEs promote proliferation of VSMCs and suppress autophagy, at least in part via CatD reduction.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25673507     DOI: 10.1007/s11010-015-2338-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  37 in total

Review 1.  Autophagy: renovation of cells and tissues.

Authors:  Noboru Mizushima; Masaaki Komatsu
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

Review 2.  Autophagic cell death and its execution by lysosomal cathepsins.

Authors:  Y Uchiyama
Journal:  Arch Histol Cytol       Date:  2001-08

3.  Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis.

Authors:  F F Hou; G M Chertow; J Kay; J Boyce; J M Lazarus; J A Braatz; W F Owen
Journal:  Kidney Int       Date:  1997-05       Impact factor: 10.612

4.  Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.

Authors:  B K Kilhovd; T J Berg; K I Birkeland; P Thorsby; K F Hanssen
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

5.  Formin mDia1 mediates vascular remodeling via integration of oxidative and signal transduction pathways.

Authors:  Fatouma Touré; Günter Fritz; Qing Li; Vivek Rai; Gurdip Daffu; Yu Shan Zou; Rosa Rosario; Ravichandran Ramasamy; Arthur S Alberts; Shi Fang Yan; Ann Marie Schmidt
Journal:  Circ Res       Date:  2012-04-17       Impact factor: 17.367

Review 6.  Advanced glycation end-products and atherosclerosis.

Authors:  H Vlassara
Journal:  Ann Med       Date:  1996-10       Impact factor: 4.709

7.  PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stress.

Authors:  Joshua K Salabei; Timothy D Cummins; Mahavir Singh; Steven P Jones; Aruni Bhatnagar; Bradford G Hill
Journal:  Biochem J       Date:  2013-05-01       Impact factor: 3.857

8.  Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells.

Authors:  Marpadga A Reddy; Shu-Lian Li; Saurabh Sahar; Young-Sook Kim; Zhong-Gao Xu; Linda Lanting; Rama Natarajan
Journal:  J Biol Chem       Date:  2006-03-21       Impact factor: 5.157

9.  Lipocalin-2 elicited by advanced glycation end-products promotes the migration of vascular smooth muscle cells.

Authors:  Tae-Wook Chung; Hee-Jung Choi; Cheorl-Ho Kim; Han-Sol Jeong; Ki-Tae Ha
Journal:  Biochim Biophys Acta       Date:  2013-10-19

10.  Thrombin up-regulates cathepsin D which enhances angiogenesis, growth, and metastasis.

Authors:  Liang Hu; Jennifer M Roth; Peter Brooks; Joanna Luty; Simon Karpatkin
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701

View more
  8 in total

Review 1.  Hypoxia driven glycation: Mechanisms and therapeutic opportunities.

Authors:  Mohammad Imran Khan; Suvasmita Rath; Vaqar Mustafa Adhami; Hasan Mukhtar
Journal:  Semin Cancer Biol       Date:  2017-05-22       Impact factor: 15.707

2.  AGE-RAGE Stress in the Pathophysiology of Pulmonary Hypertension and its Treatment.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2019-04-19

3.  Advanced Glycation End Products Inhibit the Proliferation of Human Umbilical Vein Endothelial Cells by Inhibiting Cathepsin D.

Authors:  Yuan Li; Ye Chang; Ning Ye; Dongxue Dai; Yintao Chen; Naijin Zhang; Guozhe Sun; Yingxian Sun
Journal:  Int J Mol Sci       Date:  2017-02-17       Impact factor: 5.923

4.  Advanced glycation end products promote the proliferation and migration of primary rat vascular smooth muscle cells via the upregulation of BAG3.

Authors:  Cunshu Li; Ye Chang; Yuan Li; Shuang Chen; Yintao Chen; Ning Ye; Dongxue Dai; Yingxian Sun
Journal:  Int J Mol Med       Date:  2017-03-28       Impact factor: 4.101

Review 5.  Autophagy in the Neuronal Ceroid Lipofuscinoses (Batten Disease).

Authors:  William D Kim; Morgan L D M Wilson-Smillie; Aruban Thanabalasingam; Stephane Lefrancois; Susan L Cotman; Robert J Huber
Journal:  Front Cell Dev Biol       Date:  2022-02-16

6.  Atorvastatin protects the proliferative ability of human umbilical vein endothelial cells inhibited by angiotensin II by changing mitochondrial energy metabolism.

Authors:  Ye Chang; Yuan Li; Ning Ye; Xiaofan Guo; Zhao Li; Guozhe Sun; Yingxian Sun
Journal:  Int J Mol Med       Date:  2017-10-19       Impact factor: 4.101

7.  Advanced Glycation End Products Enhance Murine Monocyte Proliferation in Bone Marrow and Prime Them into an Inflammatory Phenotype through MAPK Signaling.

Authors:  Xian Jin; Liang Liu; Yaping Zhang; Yin Xiang; Guizhi Yin; Yi Lu; Ludong Shi; Jian Dong; Chengxing Shen
Journal:  J Diabetes Res       Date:  2018-03-22       Impact factor: 4.011

8.  MicroRNA-130a inhibits proliferation of vascular smooth muscle cells by suppressing autophagy via ATG2B.

Authors:  Liang Zheng; Zhecun Wang; Zilun Li; Mian Wang; Wenjian Wang; Guangqi Chang
Journal:  J Cell Mol Med       Date:  2021-02-21       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.